Literature DB >> 18780262

Prevalence of retinitis pigmentosa in South Indian population aged above 40 years.

Parveen Sen1, Arun Bhargava, Ronnie George, S Ve Ramesh, Arvind Hemamalini, Raju Prema, Govindasamy Kumaramanickavel, Lingam Vijaya.   

Abstract

PURPOSE: The study was undertaken to evaluate the prevalence of retinitis pigmentosa (RP) in rural and urban South India.
METHODS: Seven thousand seven hundred and seventy four subjects aged 40 years or more from rural and urban Tamil Nadu, underwent comprehensive ophthalmic examination out of 9576 enumerated (81.17%). After a thorough ophthalmic examination, fundus photographs were taken for documentation. Statistical analysis was done using SPSS for Windows (ver 14).
RESULTS: 7461 (95.9%) subjects had fundus details seen in both eyes. Thirteen subjects (0.17%; 4 males, 9 females) were diagnosed as retinitis pigmentosa. Retinitis pigmentosa in the urban population was seen in approximately 1 in 930 persons, while 1 in 372 of rural subjects had the disorder. This figure is greater than other reports from the western populations and that of the conservative estimate of 1 in 4000. The age and gender adjusted prevalence rate of retinitis pigmentosa to national census 2001 was 0.155%. Eight subjects (61.53%) had visual acuity less than 3/60.
CONCLUSION: Prevalence of RP in South India appears to be alarmingly higher in comparison to those seen in other parts of the world.

Entities:  

Mesh:

Year:  2008        PMID: 18780262     DOI: 10.1080/09286580802105814

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  26 in total

Review 1.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

Review 2.  Clinical characteristics and current therapies for inherited retinal degenerations.

Authors:  José-Alain Sahel; Katia Marazova; Isabelle Audo
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-16       Impact factor: 6.915

3.  Hereditary and clinical features of retinitis pigmentosa in Koreans.

Authors:  Sun Ho Lee; Hyeong Gon Yu; Jong Mo Seo; Sang Woong Moon; Jun Woong Moon; Sang Jin Kim; Hum Chung
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

4.  Retinitis pigmentosa and allied conditions today: a paradigm of translational research.

Authors:  Carmen Ayuso; Jose M Millan
Journal:  Genome Med       Date:  2010-05-27       Impact factor: 11.117

Review 5.  Genetic Testing in Pediatric Ophthalmology.

Authors:  Ishwar Chander Verma; Preeti Paliwal; Kanika Singh
Journal:  Indian J Pediatr       Date:  2017-10-02       Impact factor: 1.967

6.  SAGE: a comprehensive resource of genetic variants integrating South Asian whole genomes and exomes.

Authors:  Judith Mary Hariprakash; Shamsudheen Karuthedath Vellarikkal; Ankit Verma; Anop Singh Ranawat; Rijith Jayarajan; Rowmika Ravi; Anoop Kumar; Vishal Dixit; Ambily Sivadas; Atul Kumar Kashyap; Vigneshwar Senthivel; Paras Sehgal; Vijayalakshmi Mahadevan; Vinod Scaria; Sridhar Sivasubbu
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

7.  Principal components' analysis of multifocal electroretinogram in retinitis pigmentosa.

Authors:  Aniruddha Maiti; Mahesh Uparkar; Sundaram Natarajan; Nishikanth Borse; Jaydeep Walinjkar
Journal:  Indian J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 1.848

8.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

9.  Decoding retinitis pigmentosa.

Authors:  Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

10.  Prevalence and pattern of vitreo-retinal diseases in Nepal: the Bhaktapur glaucoma study.

Authors:  Suman S Thapa; Raba Thapa; Indira Paudyal; Shankar Khanal; Jaskirat Aujla; Govinda Paudyal; Ger van Rens
Journal:  BMC Ophthalmol       Date:  2013-03-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.